| Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial MF Grunebaum, HC Galfalvy, TH Choo, JG Keilp, VK Moitra, MS Parris, ... American Journal of Psychiatry 175 (4), 327-335, 2018 | 261 | 2018 |
| Neuroanatomic correlates of psychopathologic components of major depressive disorder MS Milak, RV Parsey, J Keilp, MA Oquendo, KM Malone, JJ Mann Archives of General Psychiatry 62 (4), 397-408, 2005 | 249 | 2005 |
| Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations RV Parsey, RT Ogden, JM Miller, A Tin, N Hesselgrave, E Goldstein, ... Biological psychiatry 68 (2), 170-178, 2010 | 165 | 2010 |
| Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial MF Grunebaum, SP Ellis, JG Keilp, VK Moitra, TB Cooper, JE Marver, ... Bipolar disorders 19 (3), 176-183, 2017 | 117 | 2017 |
| A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder MS Milak, CJ Proper, ST Mulhern, AL Parter, LS Kegeles, RT Ogden, ... Molecular psychiatry 21 (3), 320-327, 2016 | 115 | 2016 |
| In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer MS Milak, C DeLorenzo, F Zanderigo, J Prabhakaran, JSD Kumar, ... Journal of Nuclear Medicine 51 (12), 1892-1900, 2010 | 91 | 2010 |
| Positron emission tomography quantification of serotonin1A receptor binding in suicide attempters with major depressive disorder GM Sullivan, MA Oquendo, M Milak, JM Miller, A Burke, RT Ogden, ... JAMA psychiatry 72 (2), 169-178, 2015 | 88 | 2015 |
| Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder NA Gray, MS Milak, C DeLorenzo, RT Ogden, Y Huang, JJ Mann, ... Biological psychiatry 74 (1), 26-31, 2013 | 85 | 2013 |
| Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression ME Sublette, MS Milak, JR Hibbeln, PJ Freed, MA Oquendo, KM Malone, ... Prostaglandins, leukotrienes and essential fatty acids 80 (1), 57-64, 2009 | 79 | 2009 |
| Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C] 2-(4-(4-(2-methoxyphenyl) piperazin-1-yl) butyl)-4-methyl-1, 2, 4-triazine-3, 5 … JS Kumar, J Prabhakaran, VJ Majo, MS Milak, SC Hsiung, H Tamir, ... European journal of nuclear medicine and molecular imaging 34 (7), 1050-1060, 2007 | 79 | 2007 |
| Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET MS Milak, AJ Severance, RT Ogden, J Prabhakaran, JSD Kumar, VJ Majo, ... Journal of Nuclear Medicine 49 (4), 587-596, 2008 | 64 | 2008 |
| Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment MS Milak, RV Parsey, L Lee, MA Oquendo, DM Olvet, F Eipper, K Malone, ... Psychiatry Research: Neuroimaging 173 (1), 63-70, 2009 | 62 | 2009 |
| Positron emission tomographic imaging of the serotonergic system and prediction of risk and lethality of future suicidal behavior MA Oquendo, H Galfalvy, GM Sullivan, JM Miller, MM Milak, ME Sublette, ... JAMA psychiatry 73 (10), 1048-1055, 2016 | 60 | 2016 |
| Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression ME Sublette, MS Milak, HC Galfalvy, MA Oquendo, KM Malone, JJ Mann Archives of Suicide Research 17 (4), 434-447, 2013 | 59 | 2013 |
| In vivo Serotonin-Sensitive Binding of [11C]CUMI-101: A Serotonin 1A Receptor Agonist Positron Emission Tomography Radiotracer MS Milak, AJ Severance, J Prabhakaran, JSD Kumar, VJ Majo, RT Ogden, ... Journal of Cerebral Blood Flow & Metabolism 31 (1), 243-249, 2011 | 59 | 2011 |
| Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency MS Milak, RT Ogden, DN Vinocur, RL Van Heertum, TB Cooper, JJ Mann, ... Biological psychiatry 57 (1), 102-106, 2005 | 56 | 2005 |
| In vivo positron emission tomography imaging with [11C] ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons C DeLorenzo, MS Milak, KG Brennan, JS Kumar, JJ Mann, RV Parsey European journal of nuclear medicine and molecular imaging 38 (6), 1083-1094, 2011 | 54 | 2011 |
| Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder MA Oquendo, A Krunic, RV Parsey, M Milak, KM Malone, A Anderson, ... Neuropsychopharmacology 30 (6), 1163-1172, 2005 | 52 | 2005 |
| In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: proof of concept CI Rodriguez, LS Kegeles, A Levinson, RT Ogden, X Mao, MS Milak, ... Psychiatry Research: Neuroimaging 233 (2), 141-147, 2015 | 41 | 2015 |
| Synthesis, in vitro and in vivo evaluation of [11C] MMTP: a potential PET ligand for mGluR1 receptors J Prabhakaran, VJ Majo, MS Milak, SA Kassir, M Palner, L Savenkova, ... Bioorganic & medicinal chemistry letters 20 (12), 3499-3501, 2010 | 35 | 2010 |
j. john mannColumbia University and New York State Psychiatric InstituteVerified email at columbia.edu
